Pfizer’s recent pact with UC San Francisco is the latest in big pharma’s move to the new collaborative drug development model that is part of the 21st century new medicinal product development framework that … Continue reading at ComplianceZen.com →
From the Blog
Lowering Liability Risks with Supplier Qualification
FDA Compliance Training – Free Consulting?
From the NIH – Biotechnology Landscape 2020
FDA Forecast for 2012
From the PCP Council Science Symposium
Client Success Stories
“Five years later and, in my opinion, the strategies and controls you helped us build and put into place should be the model for anyone needing to enhance productivity while dealing with regulatory compliance.”
- Timothy Beane, Vice President, Richmond, Virginia
